Hsa_circ_0021727 (circ-CD44) promotes ESCC progression by targeting miR-23b-5p to activate the TAB1/NFκB pathway

Fan Meng(First Affiliated Hospital of Gannan Medical University), Xin He(Gannan Medical University), Yulin Tang(First Affiliated Hospital of Gannan Medical University), Weiyou Liu(Gannan Medical University), Xingdu Zeng(First Affiliated Hospital of Gannan Medical University), Guisheng Zhang(Shanxi University), Xiaokang Zhang, Yanting Wang(East China University of Science and Technology), Jie Lin(Fujian Medical University), Binqiang Qiu(First Affiliated Hospital of Gannan Medical University)
Research Square
June 24, 2022
Cited by 1


Related Papers